gallic acid has been researched along with Hepatic Encephalopathy in 2 studies
gallate : A trihydroxybenzoate that is the conjugate base of gallic acid.
Hepatic Encephalopathy: A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to elucidate the effects of syringic acid on thioacetamide-induced hepatic encephalopathy which is a complex serious syndrome with neuropsychiatric abnormalities related to acute liver dysfunctions like cirrhosis." | 8.12 | Syringic acid protects against thioacetamide-induced hepatic encephalopathy: Behavioral, biochemical, and molecular evidence. ( Bayram, C; Ertugrul, MS; Ferah Okkay, I; Gundogdu, OL; Hacimuftuoglu, A; Mendil, AS; Okkay, U, 2022) |
| "The objective of this study was to elucidate the effects of syringic acid on thioacetamide-induced hepatic encephalopathy which is a complex serious syndrome with neuropsychiatric abnormalities related to acute liver dysfunctions like cirrhosis." | 4.12 | Syringic acid protects against thioacetamide-induced hepatic encephalopathy: Behavioral, biochemical, and molecular evidence. ( Bayram, C; Ertugrul, MS; Ferah Okkay, I; Gundogdu, OL; Hacimuftuoglu, A; Mendil, AS; Okkay, U, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferah Okkay, I | 1 |
| Okkay, U | 1 |
| Gundogdu, OL | 1 |
| Bayram, C | 1 |
| Mendil, AS | 1 |
| Ertugrul, MS | 1 |
| Hacimuftuoglu, A | 1 |
| Mohamed, EK | 1 |
| Hafez, DM | 1 |
2 other studies available for gallic acid and Hepatic Encephalopathy
| Article | Year |
|---|---|
Syringic acid protects against thioacetamide-induced hepatic encephalopathy: Behavioral, biochemical, and molecular evidence.
Topics: Ammonia; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cytokines; Gallic Acid; Hepatic | 2022 |
Gallic acid and metformin co-administration reduce oxidative stress, apoptosis and inflammation via Fas/caspase-3 and NF-κB signaling pathways in thioacetamide-induced acute hepatic encephalopathy in rats.
Topics: Animals; Apoptosis; Caspase 3; Gallic Acid; Hepatic Encephalopathy; Inflammation; Metformin; NF-kapp | 2023 |